Determinants of platelet conjugate formation with polymorphonuclear leukocytes or monocytes in whole blood

Summary Following preliminary in-vitro experiments, platelet-leukocyte conjugates and their determinants were evaluated in citrated whole blood from 349 subjects (209 women, age 16–92 years) randomly recruited from the general population. Platelet activation by ADP/collagen but not leukocyte stimulation by fMLP or LTB4 resulted in formation of platelet conjugates with PMN or monocytes. In the population study, mixed cell conjugates, platelet P-selectin and leukocyte CD11b were measured by flow cytometry both at baseline and after in-vitro stimulation with ADP/collagen. The latter significantly increased platelet conjugates with either PMN or monocytes, platelet P-selectin and leukocyte CD11b expression. Platelet count significantly correlated with platelet-PMN, platelet-monocyte conjugates and P-selectin both at baseline and upon stimulation. In all conditions, both conjugate levels correlated with each other, when adjusted for gender, age and platelet count. Age correlated with platelet-PMN conjugate numbers in basal and stimulated conditions and with basal P-selectin. ADP/collagen stimulation resulted in higher P-selectin and conjugates values in women. Among risk factors, a significant correlation was found between conjugate and glucose levels. In conclusion, the presence and formation in whole blood from a large population of plateletleukocyte conjugates reflects primary platelet – but not leukocyte – activation and varies with gender, age, platelet count and blood glucose.

[1]  D. Newby,et al.  Flow cytometric analysis of circulating platelet-monocyte aggregates in whole blood: Methodological considerations , 2007, Thrombosis and Haemostasis.

[2]  C. Cerletti,et al.  Parnaparin, a low-molecular-weight heparin, prevents P-selectindependent formation of platelet-leukocyte aggregates in human whole blood , 2007, Thrombosis and Haemostasis.

[3]  Vittorio Krogh,et al.  -344C/T Variant in the promoter of the aldosterone synthase gene (CYP11B2) is associated with metabolic syndrome in men. , 2007, American journal of hypertension.

[4]  C. Cerletti,et al.  Inhibition of tissue factor expression by hydroxyurea in polymorphonuclear leukocytes from patients with myeloproliferative disorders: a new effect for an old drug? , 2006, Journal of thrombosis and haemostasis : JTH.

[5]  P. Hjemdahl,et al.  High glucose levels enhance platelet activation: involvement of multiple mechanisms , 2006, British journal of haematology.

[6]  G. Boden,et al.  Platelet and monocyte activation by hyperglycemia and hyperinsulinemia in healthy subjects , 2006, Platelets.

[7]  J. Zwaginga,et al.  Leukocyte-platelet aggregates: new particles reflecting and effecting cardiovascular disease , 2005, Thrombosis and Haemostasis.

[8]  M. Furman,et al.  Effects of platelet binding on whole blood flow cytometry assays of monocyte and neutrophil procoagulant activity , 2005, Journal of thrombosis and haemostasis : JTH.

[9]  D. Wagner,et al.  The P‐selectin, tissue factor, coagulation triad , 2005, Journal of thrombosis and haemostasis : JTH.

[10]  T. Barbui,et al.  Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera. , 2005, Experimental hematology.

[11]  H. Wendel,et al.  The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[12]  O. McCarty,et al.  Preferential binding of platelets to monocytes over neutrophils under flow. , 2005, Biochemical and biophysical research communications.

[13]  J. Geng,et al.  P-selectin binding to P-selectin glycoprotein ligand-1 induces an intermediate state of alphaMbeta2 activation and acts cooperatively with extracellular stimuli to support maximal adhesion of human neutrophils. , 2004, Blood.

[14]  Zaverio M. Ruggeri,et al.  Platelets in atherothrombosis , 2002, Nature Medicine.

[15]  A. Matzdorff,et al.  Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes. , 2002, Thrombosis research.

[16]  T. Wun,et al.  Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease. , 2002, Clinical and laboratory haematology.

[17]  J. Jákó,et al.  Identification of P‐selectin glycoprotein ligand‐1 as a useful marker in acute myeloid leukaemias , 2001, British journal of haematology.

[18]  JosVermylen,et al.  Increased Mortality With Long-Term Platelet Glycoprotein IIb/IIIa Antagonists: An Explanation? , 2001 .

[19]  D. Isenberg,et al.  Increased circulating platelet–leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis , 2001, British journal of haematology.

[20]  M. Furman,et al.  Circulating Monocyte-Platelet Aggregates Are a More Sensitive Marker of In Vivo Platelet Activation Than Platelet Surface P-Selectin: Studies in Baboons, Human Coronary Intervention, and Human Acute Myocardial Infarction , 2001, Circulation.

[21]  R P McEver,et al.  Adhesive Interactions of Leukocytes, Platelets, and the Vessel Wall during Hemostasis and Inflammation , 2001, Thrombosis and Haemostasis.

[22]  C. Cerletti,et al.  Platelet/polymorphonuclear leukocyte adhesion: a new role for SRC kinases in Mac-1 adhesive function triggered by P-selectin. , 2001, Blood.

[23]  P. Hjemdahl,et al.  Platelet-Leukocyte Cross Talk in Whole Blood , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[24]  N. Maugeri,et al.  Circulating platelet/polymorphonuclear leukocyte mixed–cell aggregates in patients with mechanical heart valve replacement , 2000, American journal of hematology.

[25]  S Neelamegham,et al.  Shear and Time-Dependent Changes in Mac-1, LFA-1, and ICAM-3 Binding Regulate Neutrophil Homotypic Adhesion1 , 2000, The Journal of Immunology.

[26]  Inger Anne Hagberg, Torstein Lyberg.  Evaluation of circulating platelet–leukocyte conjugates: a sensitive flow cytometric assay well suited for clinical studies , 2000, Platelets.

[27]  C. Cerletti,et al.  P-Selectin-β2-Integrin Cross-Talk: A Molecular Mechanism For Polymorphonuclear Leukocyte Recruitment At The Site Of Vascular Damage , 1999, Thrombosis and Haemostasis.

[28]  G. Gaetano,et al.  Platelet/Polymorphonuclear Leukocyte Interaction: P-Selectin Triggers Protein-Tyrosine Phosphorylation–Dependent CD11b/CD18 Adhesion: Role of PSGL-1 as a Signaling Molecule , 1999 .

[29]  J Ludbrook,et al.  MULTIPLE COMPARISON PROCEDURES UPDATED , 1998, Clinical and experimental pharmacology & physiology.

[30]  P. Hjemdahl,et al.  A sensitive flow cytometric assay for circulating platelet–leucocyte aggregates , 1997, British journal of haematology.

[31]  T. Springer,et al.  Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor. , 1997, The Journal of clinical investigation.

[32]  P. Bray,et al.  Gender Differences in Platelet GPIIb-IIIa Activation , 1997, Thrombosis and Haemostasis.

[33]  D. Kirchhofer,et al.  Specific accumulation of circulating monocytes and polymorphonuclear leukocytes on platelet thrombi in a vascular injury model. , 1997, Blood.

[34]  C. Cerletti,et al.  Platelet/polymorphonuclear leukocyte interaction in dynamic conditions: evidence of adhesion cascade and cross talk between P-selectin and the beta 2 integrin CD11b/CD18. , 1996, Blood.

[35]  T. Springer,et al.  Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. , 1996, Blood.

[36]  C. Cerletti,et al.  Platelet Activation by Polymorphonuclear Leukocytes: Role of Cathepsin G and P-Selectin , 1995, Thrombosis and Haemostasis.

[37]  J. White,et al.  Cathepsin G-dependent platelet stimulation by activated polymorphonuclear leukocytes and its inhibition by antiproteinases: role of P-selectin-mediated cell-cell adhesion. , 1993, Blood.

[38]  C. Benjamin,et al.  Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets , 1992, Nature.

[39]  J. Dormandy,et al.  Leukocytes and the risk of ischemic diseases. , 1987, JAMA.

[40]  M. Chignard,et al.  Direct evidence for the existence of a neutrophil-derived platelet activator (neutrophilin). , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[41]  P. Ramwell,et al.  Sex and age differences in human platelet aggregation , 1975, Nature.

[42]  N. Villamor,et al.  Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status. , 2006, Haematologica.

[43]  B. Furie,et al.  The Biology of P-Selectin Glycoprotein Ligand-1: Its Role as a Selectin Counterreceptor in Leukocyte-Endothelial and Leukocyte-Platelet Interaction , 1999, Thrombosis and Haemostasis.

[44]  B. Smith,et al.  Dynamics of leukocyte-platelet adhesion in whole blood. , 1991, Blood.